Study guide

3.4 Phlebitis: Prevention, Grading & Management

CRNI® Exam Study Guide Certified Registered Nurse Infusion

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application & Testing Windows 1.3 Scoring, Results & Recertification

2 Anatomy & Physiology for Infusion Practice

2.1 Vascular Anatomy & Physiology for Infusion 2.2 Body Positioning for Catheter Insertion & Removal 2.3 Vein Selection & Patient Assessment

3 Infection Prevention & Control

3.1 Infection Prevention Strategies & Standard Precautions 3.2 Chain of Infection in Infusion Practice 3.3 Bloodstream Infections & CLABSI Prevention 3.4 Phlebitis: Prevention, Grading & Management

4 Phlebotomy in Infusion Practice

4.1 Blood Sampling & Blood Culture Collection 4.2 Therapeutic Phlebotomy

5 Infusion Equipment & Technology

5.1 Solution Containers, Administration Sets & Filters 5.2 Add-on Devices, Administration Devices & Closed Systems 5.3 Vein Location Devices, Navigation Tools & Securement

6 Peripheral Venous Access Devices

6.1 Short & Long Peripheral Intravenous Catheters 6.2 Midline Catheters 6.3 Peripheral Device Selection Criteria

7 Central Venous Access Devices

7.1 Peripherally Inserted Central Catheters (PICC) 7.2 Non-tunneled Central Venous Catheters 7.3 Tunneled Central Venous Catheters 7.4 Implanted Ports

8 Alternate Access Routes & Device Maintenance

8.1 Subcutaneous Infusion Access 8.2 Intraosseous Access 8.3 Device Maintenance & Care Protocols

9 Special Populations in Infusion Therapy

9.1 Older Adults & Chronic Renal Conditions 9.2 Pediatrics, Immunocompromised, Oncology & Bariatrics

10 Device-Related Complications

10.1 Infiltration & Extravasation 10.2 Catheter Occlusion 10.3 Thrombosis, Air Embolism & Device-Related Systemic Events

11 Fluid & Electrolyte Balance

11.1 Body Composition & Fluid Balance 11.2 Fluid Volume Excess & Deficit 11.3 Electrolyte Disorders 11.4 Maintenance & Replacement Fluids

12 Parenteral Nutrition

12.1 Parenteral Nutrition: Solution Composition 12.2 PN Infectious, Metabolic & Mechanical Complications

13 Anti-infectives, Blood Products & Biologics

13.1 Anti-infective Infusion Therapy 13.2 Blood Products & Transfusion Therapy 13.3 Biologics & Immunologic Therapies

14 Antineoplastic, Cardiovascular & Pain Infusions

14.1 Antineoplastic Infusion Therapy 14.2 Cardiovascular Infusions 14.3 Pain Management Infusions

15 Therapy-Related Complications & Hazardous Drugs

15.1 Rate-Related Complications 15.2 Adverse Drug Reactions 15.3 Hazardous Drug Exposure & Waste Disposal

16 Professional Practice, Documentation & Quality

16.1 Assessment, Consent & Collaborative Care Planning 16.2 Documentation, Laws & Regulatory Agencies 16.3 Evidence-Based Practice & Performance Improvement

3.4 Phlebitis: Prevention, Grading & Management

Key Takeaways Explain This Topic AI

Phlebitis is inflammation of the vein and may be chemical, mechanical, infectious, or mixed—do not assume every red site is only “irritation.”

Risk rises with larger gauge catheters, poor site choice (areas of flexion), irritating infusates, prolonged dwell, inadequate securement, and breaks in asepsis.

The INS Phlebitis Scale grades 0-4: Grade 1 is erythema with or without pain, Grade 2 adds pain with erythema and/or edema, Grade 3 adds streak formation and a palpable venous cord, and Grade 4 adds a cord longer than 1 inch plus purulent drainage.

Prevention rests on device and site selection, dilution and rate strategies for irritants, securement, routine site assessment, and aseptic technique; management is stopping the infusion, removing the catheter when indicated, restarting elsewhere if therapy continues, comfort measures such as a warm compress, and escalating when infection is suspected.

The 9th edition Infusion Therapy Standards of Practice widened the post-infusion phlebitis window from within 48 hours to 48-96 hours after catheter removal, with reported rates of roughly 1%-23%.

Last updated: August 2026

What phlebitis is—and why infusion nurses own it

Phlebitis is inflammation of a vein. In infusion therapy it most often involves peripheral veins used for short peripheral catheters, but similar inflammatory and infectious processes can affect longer peripherals, midlines, and central device tracts or tunnels in different forms. Phlebitis causes pain, interrupts therapy, consumes new insertion attempts, and—when infectious—can progress to suppurative thrombophlebitis or bloodstream infection.

CRNI Domain 1B groups phlebitis with infection prevention strategies because infectious phlebitis is on the continuum of device-related infection, and because many “non-infectious” cases are still prevented by the same habits: right device, right site, right technique, right monitoring.

  • Mechanisms: chemical, mechanical, infectious
  • Chemical phlebitis

Caused by the infusate or medication irritating the endothelium. Contributors include:

  • Extremes of pH (very acidic or alkaline drugs)
  • High osmolarity solutions
  • Vesicants/irritants given peripherally when central administration is indicated
  • Particulate matter or inadequate filtration when filtration is required

Concentrated electrolytes (e.g., higher-concentration potassium, some electrolytes) infused too quickly into small veins

Prevention levers: dilute per drug references when appropriate, use recommended final concentrations, control rate, choose a larger vein or more appropriate device (midline/central) for prolonged irritant therapy, and verify compatibility.

Mechanical phlebitis

Caused by physical trauma to the vein wall:

  • Catheter too large for the vein (high catheter-to-vein ratio)
  • Insertion site over areas of flexion (antecubital fossa for continuous infusions is a classic problem)
  • Poor securement allowing in-and-out motion (pistoning)
  • Traumatic insertion with multiple attempts
  • Catheter material stiffness and patient movement

Prevention levers: smallest gauge that meets therapy needs, avoid flexion sites for continuous infusions when possible, use engineered securement devices, stabilize during patient activity, and limit unnecessary catheter manipulation.

Infectious phlebitis

Caused by microbial invasion of the vein or peri-catheter tissues. May follow breaks in aseptic technique, contaminated solutions, or migration of skin flora. Signs can overlap with chemical/mechanical inflammation early, then progress to purulence, fever, or systemic infection.

Prevention levers: hand hygiene, skin antisepsis with dry time, non-touch of key parts, hub disinfection, intact dressings, and prompt removal of catheters that are no longer needed or that show infectious signs.

Mixed etiology is common —an irritant drug in a poorly secured large catheter at the wrist can produce chemical plus mechanical injury that then becomes secondarily infected.

Grading phlebitis: the INS Phlebitis Scale

Standardized grading improves communication and triggers action before severe injury. The INS Phlebitis Scale is the 0–4 tool published in the Infusion Therapy Standards of Practice , and it is the scale CRNI stems are built around. Learn it as a cumulative ladder —each grade adds findings on top of the grade below it.

  • Grade Clinical criteria (INS Phlebitis Scale) Usual action
  • 0 No symptoms Continue routine assessment
  • 1 Erythema at access site with or without pain Increase monitoring; address cause (rate, drug, securement)
  • 2 Pain at access site with erythema and/or edema Remove catheter; restart elsewhere if therapy continues

3 Pain with erythema and/or edema plus streak formation plus palpable venous cord Remove; escalate assessment; document; reconsider device and therapy plan

4 All Grade 3 findings plus palpable venous cord >1 inch (2.5 cm) plus purulent drainage Remove; treat as possible infection—cultures, provider notification, source control

How to read the scale on exam stems:

Grade 1 is erythema-driven; Grade 2 requires pain. Redness alone with no pain is Grade 1, not Grade 2.

Streak formation and a palpable cord first appear at Grade 3. A "red line tracking up the arm" is never Grade 1 or 2.

Purulent drainage is the Grade 4 discriminator. Purulence means you have moved from managing inflammation to managing suspected infection.

Many organizations set the escalation trigger at Grade 2 or higher (report and remove). Know your policy—but know the scale itself, because the exam tests the scale.

Do not confuse it with the VIP Score. The Visual Infusion Phlebitis (VIP) Score is a separate bedside tool (a 0–5 scale attributed to Jackson) that counts how many of pain, redness, and swelling are present; some organizations adopt it instead. When a question names the INS Phlebitis Scale , answer from the 0–4 table above.

Post-infusion phlebitis

Phlebitis can appear after the catheter is out. The 9th edition of the Infusion Therapy Standards of Practice widened the recognized post-infusion window from within 48 hours to 48–96 hours after removal , with reported rates spanning roughly 1%–23% . Practical consequence: teach patients to report new redness, pain, or a cord at a discontinued IV site for several days after removal, and never assume a site is "safe" the moment the catheter comes out.

Assessment technique:

Inspect and gently palpate the site through a transparent dressing when possible without disrupting integrity unnecessarily.

Compare to opposite limb when helpful.

Ask about pain during infusion (chemical phlebitis often hurts more when the drug is running).

Note when signs started relative to a new medication, rate change, or dressing failure.

Document grade/findings, catheter type/gauge/site, infusates, and actions.

Exam trap: Continuing a vesicant or known irritant through a painful, erythematous peripheral site “because blood return is still present.” Blood return does not make an inflamed vein safe.

  • Risk factors to cluster for exam stems
  • Gauge and length: larger diameters increase mechanical risk relative to vein size
  • Site: hands/wrists and antecubital continuous infusions; areas of dermatitis or prior phlebitis
  • Therapy: antibiotics with high irritation potential, chemo irritants, hyperosmolar solutions, vasoactive drugs
  • Duration: longer dwell without reassessment
  • Technique: traumatic starts, poor asepsis, inadequate securement

Host: fragile veins, older adults, women (epidemiologic associations in some studies), immunosuppression for infectious progression

Prevention strategies that actually work

Match device to therapy. Short peripheral for short, non-irritant therapy; consider midline or central access when osmolarity, pH, duration, or vesicant status demand it.

Vein and site selection. Prefer straight, soft veins away from joints for continuous infusions; use visualization tools when appropriate to reduce attempts.

Smallest effective gauge. Do not default to large-bore catheters “just in case” for routine fluids.

Aseptic insertion and maintenance. Full skin prep dry time; protect key parts; disinfect hubs.

Securement and dressing. Prevent motion and keep the site clean/dry/intact; replace dressings per policy or sooner if compromised.

Drug administration practices. Correct dilution, rate, filters when required, and compatibility; use central route when indicated by drug references/INS standards of practice principles.

Routine monitoring. At least each shift and with every access for inpatients (follow policy); teach outpatients to report pain, redness, swelling immediately.

Timely removal. Remove at first clear signs of phlebitis meeting removal criteria, and whenever the device is unnecessary.

Management algorithm

When phlebitis is identified:

Stop the infusion through the affected catheter.

Assess severity and look for infectious features (purulence, fever, rapid progression, severe pain).

Remove the catheter when indicated by grade, pain, therapy type, or infection concern—do not “wait and see” through progressive VIP findings.

If ongoing IV therapy is required, restart in the opposite extremity when possible, using a new catheter and fresh site; escalate device type if chemical risk is high.

Comfort measures: elevation of the limb if helpful; warm compress is often used for chemical/mechanical phlebitis after removal when not contraindicated—follow protocol. Avoid aggressive massage of a suspected infected or thrombosed cord.

Notify the provider for moderate–severe findings, suspected infection, or if vesicant/irritant extravasation is also possible (remember infiltration/extravasation is a related but distinct complication covered elsewhere).

Culture and antibiotics when infection is suspected—especially with purulence or systemic signs; consider blood cultures if BSI is possible.

Document thoroughly for continuity and quality tracking (phlebitis rates are a common quality indicator).

Do not routinely irrigate a purulent peripheral site catheter as treatment, force flush against resistance, or leave an unnecessary central line in place while chasing peripheral phlebitis problems that signal overall access-planning failure.

  • Differentiating related complications
  • Infiltration: non-vesicant fluid into tissue—cool swelling, blanching; not primarily venous inflammation
  • Extravasation: vesicant into tissue—can devastate tissue; emergency protocols apply
  • Thrombophlebitis: inflammation with thrombus; palpable cord may be present
  • Cellulitis / exit-site infection: soft-tissue infection around the site; may coexist with phlebitis
  • CRBSI: systemic infection sourced to catheter—may occur with or without dramatic local signs

Exam items may mix these; anchor on local venous inflammatory signs along the vessel path for phlebitis grading.

Quality improvement angle

Units track peripheral phlebitis rates, often per 1,000 catheter days. Spikes prompt review of securement products, irritant administration practices, dwell-time policies, and competency. For the individual CRNI nurse, the “QI move” at the bedside is simple: prevent the preventable mechanical and chemical insults, treat early grades decisively, and never normalize a painful red cord.

  • High-yield exam traps
  • Attributing all redness to tape allergy without assessing the vein path
  • Continuing infusions through progressive phlebitis because the pump is not alarming
  • Using a large-gauge AC site for multi-day antibiotic irritants instead of planning appropriate access
  • Managing suspected infectious phlebitis with warm compress only and no removal/escalation

Confusing phlebitis prevention with CLABSI bundles—overlap exists (asepsis), but mechanical/chemical planning is uniquely central to peripheral phlebitis

Integrate phlebitis knowledge with Section 3.1 strategies and Section 3.3 infection response: same aseptic foundation, different clinical grading and device decisions. That integration is exactly what Domain 1B expects.